Table 1.
Healthy controls | BDD | ||
---|---|---|---|
N: | 44 | 49 | |
Age | 25.34 ± 7.80 years | 26.43 ± 7.79 | p=0.50 |
Sex | 30 Females 14 Males | 37 Females 12 Males | p=0.58 |
Scanner: | 21 Trio 23 Allegra | 23 Trio 26 Allegra | p>0.99 |
Illness duration (years): | -- | 12.42 ± 9.56 | -- |
BDD-YBOCS | -- | 29.82 ± 5.51 | -- |
BABS | -- | 15.15 ± 3.31 | -- |
HAMA | 1.59 ± 1.54 | 12.39 ± 7.89 | p<0.01* |
HAMD (26 BDD subjects, 23 HC subjects) | 1.35 ± 1.50 | 10.92 ± 6.53 | p<0.01* |
MADRS (23 BDD subjects, 21 HC subjects) | 0.57 ± 0.93 | 17.87 ± 8.10 | p<0.01* |
Comorbidity | -- | None (n=23) Agoraphobia (n=1) Dysthymia (n= 1) Dysthymia, GAD (n=2) GAD (n=5) MDD (n=9) GAD, MDD (n=6) GAD, MDD, social phobia (n=1) SAD (n=2) |
-- |
The demographic and psychometric information for the body dysmorphic disorder (BDD) and healthy control participants is listed (mean ± standard deviation), along with p-values for two-tailed unpaired t-tests for continuous variables and chi-squared tests for binary variables.